Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Geovax, Inc.

Clinical trials sponsored by Geovax, Inc., explained in plain language.

GeoVax, Inc. GOVX NASDAQ

A clinical-stage biotech developing vaccines and immunotherapies for infectious diseases and cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New vaccine aims to better protect blood cancer patients from COVID-19

⭐️ VACCINE ⭐️ Ongoing

This study tests a new COVID-19 vaccine (GEO-CM04S1) in 63 adults with blood cancers like leukemia or lymphoma who have had a stem cell transplant or cell therapy. The goal is to see if this vaccine triggers a stronger immune response than standard mRNA vaccines, potentially offe…

Phase: PHASE2 • Sponsor: GeoVax, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 09:04 UTC